Line 224: | Line 224: | ||
<a href="https://2017.igem.org/Team:Tuebingen/Inspiration"style="margin-right:1.5em;">Inspiration</a> | <a href="https://2017.igem.org/Team:Tuebingen/Inspiration"style="margin-right:1.5em;">Inspiration</a> | ||
<a href="https://2017.igem.org/Team:Tuebingen/Demonstrate"style="margin-right:1.5em;">Results</a> | <a href="https://2017.igem.org/Team:Tuebingen/Demonstrate"style="margin-right:1.5em;">Results</a> | ||
− | <a href="https://2017.igem.org/Team:Tuebingen/HP/ | + | <a href="https://2017.igem.org/Team:Tuebingen/HP/"style="margin-right:1.5em;">Human Practice</a> |
<a href="https://2017.igem.org/Team:Tuebingen/Lab"style="margin-right:1.5em;">Lab</a> | <a href="https://2017.igem.org/Team:Tuebingen/Lab"style="margin-right:1.5em;">Lab</a> | ||
<a href="https://2017.igem.org/Team:Tuebingen/Attributions"style="margin-right:1.5em;">Attributions</a> | <a href="https://2017.igem.org/Team:Tuebingen/Attributions"style="margin-right:1.5em;">Attributions</a> | ||
</div> | </div> | ||
− | + | ||
Revision as of 01:49, 2 November 2017
Basic Parts
BBa_K2372004
SHV-1 is a β-lactamase that mediates resistance against ꞵ-lactams
BBa_K2372000
CouL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics
BBa_K2372001
CloL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics
BBa_K2372002
β-lactam synthetase (BLS) catalyzes the formation of the β-lactam ring of clavulanic acid
BBa_K2372003
The BLS mutant is a rationally designed mutant of the β-lactam synthetase
BBa_K2372005
Gyrase B (GyrB)is a type II topoisomerase
BBa_K2372006
Gyrase B (GyrB)is a type II topoisomerase